Navigation Links
Synthetic Biology: Coming Up Fast!
Date:10/27/2008

WASHINGTON Synthetic biology is being touted by scientists and venture capitalists as "the next big thing." Researchers claim to be on the brink of creating artificial life in a laboratory and making the world's first synthetic microbes. The first blockbuster synbio drugan affordable cure for malariais expected on the market by 2010. And a whole new biofuels industry spawned by synthetic biologists that promises to conquer the globe's energy problems seems just around the corner.

But will the promises and pitfalls of synthetic biology catch governments, ethicists, biosafety and biosecurity experts, and the public by surprise? Denise Caruso, former New York Times columnist and longtime analyst of technology-based issues and industries, will explore this question with the Center for American Progress's Rick Weiss. Caruso is the author of Intervention: Confronting the Real Risks of Genetic Engineering and Life on a Biotech Planet (2006). Weiss recently left The Washington Post after a distinguished career as one of the country's foremost science journalists.

Synthetic biology is an emerging area of research that uses advanced science and engineering to make or redesign living organisms, such as bacteria, so that they can carry out specific functions. The Rathenau Instituut describes the field as the convergence of molecular biology, information technology and nanotechnology, leading to the systematic design of biological systems.

This program is being jointly sponsored by the Project on Emerging Nanotechnologies and the Center for American Progress.

To attend the event, RSVP to nano@wilsoncenter.org. No RSVP is required to view the Web cast.

*** Webcast LIVE at www.wilsoncenter.org ***

What: Synthetic Biology: Coming Up Fast!

When: Friday, November 14, 2008, 12:30 1:30 PM (Light lunch available in 6th Floor Board Room prior to the event at 11:45 a.m.)

Who: Denise Caruso, Executive Director & Chair, Hybrid Vigor Institute
Rick Weiss, Senior Fellow, Center for American Progress, Moderator
David Rejeski, Director, Project on Emerging Nanotechnologies, Introduction

Where: Woodrow Wilson International Center for Scholars, 6th Floor Auditorium, in the Ronald Reagan Building at 1300 Pennsylvania Avenue, NW, Washington, DC. For directions see: http://www.wilsoncenter.org/directions


'/>"/>

Contact: Colin Finan
colin.finan@wilsoncenter.org
202-691-4321
Project on Emerging Nanotechnologies
Source:Eurekalert

Related biology news :

1. Caltech engineers build firast-ever multi-input plug-and-play synthetic RNA device
2. New synthetic form of protein holds promise to stop cancer spread
3. Synthetic moleculues could add spice to fight against cancer
4. Synthetic molecules emulate enzyme behavior for the first time
5. Synthetic cocoa chemical slows growth of tumors in human cell lines
6. Synthetic Biology: funders move to address social and ethical challenges
7. New projects to raise UK profile in synthetic biology
8. Oregano oil works as well as synthetic insecticides to tackle common beetle pest
9. Berkeley researchers identify photosynthetic dimmer switch
10. Synthetic molecules may be less expensive alternative to therapeutic antibodies, researchers find
11. Researchers decode genetics of rare photosynthetic bacterium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... SAN FRANCISCO and BANGALORE, India ... part of EdgeVerve Systems, a product subsidiary of Infosys (NYSE: ... service provider, today announced a global partnership that ... convenient way to use mobile banking and payment services. ... Mobility is a key innovation area for financial services, but ...
(Date:4/26/2016)... and LONDON , ... Finacle, part of EdgeVerve Systems, a product subsidiary ... Onegini today announced a partnership to integrate the ...      (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ) ... provide their customers enhanced security to access and ...
(Date:4/19/2016)... 20, 2016 The new GEZE ... compact web-based "all-in-one" system solution for all door components. ... or the door interface with integration authorization management system, ... systems. The minimal dimensions of the access control and ... building installations offer considerable freedom of design with regard ...
Breaking Biology News(10 mins):
(Date:5/18/2016)... Calif. (PRWEB) , ... May 18, 2016 , ... ... awarded the Luis Villalobos Award to Cognition Therapeutics at the annual ACA Summit last ... company that is financed by one of ACA’s member angel groups. It is the ...
(Date:5/18/2016)... , May 18, 2016 The Biotech ... does not mean that there are no opportunities ahead. Today, ... Inc. (NASDAQ: THLD ), Seattle Genetics Inc. (NASDAQ: ... ), and Ophthotech Corp. (NASDAQ: OPHT ). Sign ... at: http://www.activewallst.com/ Threshold Pharmaceuticals ...
(Date:5/18/2016)... ... 18, 2016 , ... Every day, more than 5,400 ER ... Costing more than $56 billion in direct costs annually, asthma remains a critical ... the suffering associated with uncontrolled asthma can be overwhelmingly disproportionate and better managed,” ...
(Date:5/18/2016)... ... ... Ryan Benton was diagnosed with Duchenne Muscular Dystrophy (DMD) at the age ... DMD is a relatively common progressive genetic disorder, which causes aggressive deterioration of the ... He met with the founder of the Stem Cell Institute in Panama ...
Breaking Biology Technology: